Form 4 holding
PRESIDENT, TBIL
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 110,319
- Estimated value
- $1,135,183
- Report date
- 18 Feb 2022
- Price
- $10.29
- Ownership
- Direct
Ann Brady
Insider Reports History
- Location
- South San Francisco, CA
- Signature
- /s/ Brett A. Grimaud, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Ann Brady:
Insider Reports Filed by Ann Brady
4
TBPH
Theravance Biopharma, Inc.
- Report period
- 18 Feb 2022
- Transactions
- 1
- Transaction value
- -$80,426
- Filing time
- 23 Feb 2022, 17:18
- Role
- PRESIDENT, TBIL
- Next action
- Open filing details
4
TBPH
Theravance Biopharma, Inc.
- Report period
- 19 Nov 2021
- Transactions
- 1
- Transaction value
- -$26,493
- Filing time
- 23 Nov 2021, 19:26
- Role
- PRESIDENT, TBIL
- Next action
- Open filing details
4
TBPH
Theravance Biopharma, Inc.
- Report period
- 20 Aug 2021
- Transactions
- 1
- Transaction value
- -$44,524
- Filing time
- 24 Aug 2021, 18:50
- Role
- President, TBIL
- Next action
- Open filing details
4
TBPH
Theravance Biopharma, Inc.
- Report period
- 20 May 2021
- Transactions
- 1
- Transaction value
- -$56,408
- Filing time
- 24 May 2021, 18:07
- Role
- President, TBIL
- Next action
- Open filing details